{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:44:07Z","timestamp":1761237847831},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.expneurol.2011.10.008","type":"journal-article","created":{"date-parts":[[2011,10,23]],"date-time":"2011-10-23T03:00:43Z","timestamp":1319338843000},"page":"118-120","source":"Crossref","is-referenced-by-count":2,"title":["Do we still need to develop new imaging biomarkers of dopamine denervation for Parkinson's disease?"],"prefix":"10.1016","volume":"233","author":[{"given":"Nicola","family":"Pavese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2011.10.008_bb0005","first-page":"855","article-title":"Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT","volume":"44","author":"Davis","year":"2003","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.expneurol.2011.10.008_bb0010","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2011.10.008_bb0015","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1471-4159.1987.tb05629.x","article-title":"Cerebral metabolism of 6-[18F]fluoro-l-3,4-dihydroxyphenylalanine in the primate","volume":"48","author":"Firnau","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2011.10.008_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/305137a0","article-title":"Dopamine visualized in the basal ganglia of living man","volume":"305","author":"Garnett","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2011.10.008_bb0025","first-page":"119","article-title":"Fluorine-18-FPCT: a PET radiotracer for imaging dopamine transporters","volume":"38","author":"Goodman","year":"1997","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.expneurol.2011.10.008_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0969-8051(99)00080-3","article-title":"18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters","volume":"27","author":"Goodman","year":"2000","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.expneurol.2011.10.008_bb0035","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4","article-title":"In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopamine nerve terminals in Parkinson's disease","volume":"47","author":"Lee","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2011.10.008_bb0040","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.expneurol.2010.08.024","article-title":"(18)F-FECNT: validation as PET dopamine transporter ligand in parkinsonism","volume":"226","author":"Masilamoni","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.10.008_bb0045","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/brain\/119.2.585","article-title":"An 18F-dopa PET and clinical study of the rate of progression in Parkinson's disease","volume":"119","author":"Morrish","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2011.10.008_bb0050","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/syn.20431","article-title":"Progressive changes of pre- and post-synaptic dopaminergic biomarkers in conscious MPTP-treated cynomolgus monkeys measured by positron emission tomography","volume":"61","author":"Nagai","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2011.10.008_bb0055","first-page":"439","article-title":"Investigating the dopaminergic synapse in vivo. I. Molecular imaging studies in humans","volume":"18","author":"Nikolaus","year":"2007","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2011.10.008_bb0060","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2967\/jnumed.109.070094","article-title":"In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133","volume":"51","author":"Okamura","year":"2010","journal-title":"J. Nucl. Med."},{"issue":"Suppl. 4","key":"10.1016\/j.expneurol.2011.10.008_bb0065","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S1353-8020(09)70832-6","article-title":"Neuroprotection and imaging studies in Parkinson's disease","volume":"15","author":"Pavese","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2011.10.008_bb0070","first-page":"36","article-title":"Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging","volume":"41","author":"Pirker","year":"2000","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.expneurol.2011.10.008_bb0075","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/archneur.59.4.580","article-title":"Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease","volume":"59","author":"Ribeiro","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2011.10.008_bb0080","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/syn.10068","article-title":"Measurement of dopamine transporter occupancy for multiple injections of cocaine using a single injection of [F-18]FECNT","volume":"44","author":"Votaw","year":"2002","journal-title":"Synapse"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611003797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611003797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T07:24:38Z","timestamp":1543476278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488611003797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0014488611003797"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2011.10.008","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}